Dr. Cristian Massacesi named executive vice president, chief medical officer and head of development at Bristol Myers Squibb
He will oversee the company’s early-stage and late-stage product development across all therapeutic areas.
Pharmacy
NCPA applauds bill to reimburse pharmacists for treating COVID, flu, and other ailments
“This legislation protects patient access, especially for people in rural areas where pharmacists can be the only healthcare provider for many miles,” said NCPA CEO B. Douglas Hoey.
NACDS praises Senate action to ensure seniors on Medicare have access to certain state-approved pharmacist services
Bipartisan bill stands to enhance healthcare delivery for seniors nationwide, especially those in communities where provider shortages persist.
NCPA announces finalists for 2025 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition
The winning team will be announced on Sunday, Oct. 19, as part of the convention’s First General Session.
UnitedHealth Group discloses DOJ investigation into Medicare billing practices
The company emphasized it has “full confidence in its practices” and is “committed to working cooperatively” with federal investigators.
Roche considers direct-to-patient sales in U.S. amid earnings beat
The Swiss drugmaker is in active discussions with the U.S. government regarding a plan that could eliminate middlemen, such as pharmacy benefit managers (PBMs).
CVS Health opens new Workforce Innovation and Talent Center in Columbus, Ohio
The new facility at Rosewind Community Center offers free workforce training and access to health services.
HHS adopts ACIP recommendation to remove thimerosal from all U.S. influenza vaccines
This move follows a 5-1-1 vote at the ACIP’s June 25-26 meeting at CDC headquarters in Atlanta, where committee members voted that all children 18 years and younger, pregnant women, and adults receive only single-dose influenza vaccines free of mercury.
George Tidmarsh named director of Center for Drug Evaluation and Research
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development—from bench to bedside,” said FDA Commissioner Dr. Marty Makary.
Scripta Insights unveils Fiduciary Protection Program
Scripta’s Rx Navigator, a price transparency tool, provides visibility into drug costs, enabling employers to lower costs, reduce legal exposure and enhance fiduciary oversight.
Milken Institute unveils report to advance pharmacy-based healthcare access
Action-driven framework, supported by NACDS, sets the stage for pharmacies as engines of disease prevention and whole-person health.
Rx relief ranks among SIA's 40 largest allied healthcare staffing firms
"This recognition just illustrates the trust our clients and talent continue to place in us."
AAM congratulates Dr. Tidmarsh on appointment as CDER director
“We look forward to a collaborative partnership with Dr. Tidmarsh and the larger team at CDER to prioritize regulatory efficiency.”
UVA Health experts warn GLP-1 drugs may not provide key long-term weight-loss benefit
Doctors may need to consider recommending exercise programs or develop other approaches, such as nutrition supplements or complementary medications, to help GLP-1 patients get the full cardiorespiratory benefits of substantial weight loss over the long-run, the researchers say.
Amneal announces proposed refinancing of existing credit agreement
The proposed transactions are subject to market conditions and other factors, and there can be no assurance as to whether or when these transactions may be completed, or as to the actual size or terms of the transactions.
Good Neighbor Pharmacy honors independent pharmacy excellence at ThoughtSpot 2025
A highlight was the presentation of the 2025 Good Neighbor Pharmacy Champion Awards, recognizing three member pharmacies for leadership in advocacy, clinical care, and patient engagement.